Search
Oncology Institute Inc
TOIAdd to Watchlist
5.280USD
-0.230-4.17%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
522.00MMarket Cap
LossP/E TTM
Revenue Breakdown
Currency: USDUpdated: Mon, Apr 6
Currency: USDUpdated: Mon, Apr 6
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
By BusinessUSD
Name
Revenue
Proportion
Dispensary revenue
269.18M
53.54%
FFS revenue
148.51M
29.54%
Capitated revenue
80.48M
16.01%
Clinical research trials and other revenue
4.56M
0.91%
Relevant data have not been disclosed by the company yet.
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Dispensary revenue
269.18M
53.54%
FFS revenue
148.51M
29.54%
Capitated revenue
80.48M
16.01%
Clinical research trials and other revenue
4.56M
0.91%